ISABEL BECKETT: Open Payments
NPI 1649884438 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,604 in 85 payments from 17 companies in 2025. Trend: 2023 $152 · 2024 $1,540 · 2025 $3,604
Food & beverage: $3,367Travel & lodging: $237
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 33 | $864 |
| LivaNova USA, Inc. | 4 | $757 |
| Teva Pharmaceuticals USA, Inc. | 9 | $286 |
| Boston Scientific Corporation | 2 | $285 |
| ABIOMED | 2 | $268 |
| Neurelis, Inc. | 5 | $162 |
| SK Life Science, Inc. | 4 | $157 |
| JAZZ PHARMACEUTICALS INC. | 5 | $144 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| ACADIA Pharmaceuticals Inc | 1 | $122 |
Products named: VNS Therapy, Fintepla, AUSTEDO XR, Nayzilam, VALTOCO, Briviact, EPIDIOLEX, AMS 700.
Industry payments across TX — which companies pay providers there.
